DULAS’S NEW REFRIGERATION RANGE ADDRESSES STAGGERING VACCINE LOSSES CAUSED BY COLD CHAIN FAILURES

With nearly £2.9 million[1] worth of vaccines lost annually due to cold chain issues, the ongoing need for innovative and reliable vaccine storage solutions is stark. Dulas, a leader in renewable energy solutions for over 40 years, is set to launch a new range specifically for the pharmacy and laboratory sectors in its continued quest to provide leading-edge refrigeration solutions.

Many medications need to be stored between 2-8°C to maintain their efficacy. Temperature sensitive pharmaceuticals can lose potency when storage temperatures fall outside this range, becoming ineffective or even harmful. Significant financial losses and severe impact on vaccination campaigns can be the result, as valuable vaccines must be discarded, which can ultimately leave communities vulnerable to preventable diseases.

Known for its pioneering solar-powered off-grid vaccine storage systems, Dulas has supported vital immunisation programmes and helped combat climate change across the globe for over 40 years. Now, having completed a series of strategic acquisitions and with innovative product launches on the horizon, Dulas is extending its expertise to serve the pharmacy and laboratory sectors.  

To underpin this growth and provide greater clarity to its customers - whilst staying true to its core mission of supporting both people and planet with a strong sense of purpose - Dulas has launched a new sub-division.

Dulas Life Sciences will focus on vaccine storage products, cooled incubators, and the soon-to-be-launched new refrigeration range for the pharmacy and laboratory sectors - addressing cold chain failures by offering highly reliable, UK-manufactured systems.

The new refrigeration range, Dulas Connected, includes features that will revolutionise efficiency and security for the sector. 

Several preventable factors cause pharmaceutical loss, including doors being left open, poor-performing fridges, and lack of proper temperature monitoring, as well as unavoidable incidents such as power outages. Proper equipment and continuous temperature monitoring are crucial to maintaining efficiency and safeguarding public health. By providing real-time alerts if temperatures go out of range, Dulas Connected refrigerators provide users with valuable information for storing vaccines.

Whilst Dulas may be a new name to those in the UK pharmacy sector, it brings vast experience in medical refrigeration, having supplied trusted brands behind the scenes for decades. With over 40 years of expertise from Dulas’s renowned solar fridge division, which is fully WHO Performance, Quality and Safety (PQS) accredited, the new range promises the same high quality in tech and build.

“Our new refrigeration range is designed to prevent the devastating losses caused by cold chain failures, ensuring that vaccines and other critical medical supplies are kept safe,” said Ruth Chapman, Executive Managing Director at Dulas. “The smart features of our refrigerators give users more information than any other fridge on the market. They provide real-time alerts if temperatures go out of range, and you can track the exact duration of time a fridge has been too hot or too cold for. This is vital for safeguarding vaccines, as they can only remain outside the temperature range for a limited time before needing to be discarded. With Dulas, you can relax knowing that fridge temperature data is monitored in real-time and delivered instantly.”

The Dulas Connected Refrigeration Range brings together decades of manufacturing expertise to offer sustainable, reliable products that meet the highest standards for medical refrigeration. 

Full details of the range, along with its unique features, will be presented at the Pharmacy Show, on stand C56, offering attendees a first-hand look at how these products will support critical healthcare needs. 

[1] https://www.gov.uk/government/publications/vaccine-update-issue-338-may-2023/vaccine-update-issue-338-may-2023